ITMI912310A1 - Dermatan solfato ad alto titolo, dotato di elevata attivita' trombolitica, e forme farmaceutiche che lo contengono. - Google Patents

Dermatan solfato ad alto titolo, dotato di elevata attivita' trombolitica, e forme farmaceutiche che lo contengono.

Info

Publication number
ITMI912310A1
ITMI912310A1 IT002310A ITMI912310A ITMI912310A1 IT MI912310 A1 ITMI912310 A1 IT MI912310A1 IT 002310 A IT002310 A IT 002310A IT MI912310 A ITMI912310 A IT MI912310A IT MI912310 A1 ITMI912310 A1 IT MI912310A1
Authority
IT
Italy
Prior art keywords
pct
activity
thrombolithic
dermatan sulphate
contain
Prior art date
Application number
IT002310A
Other languages
English (en)
Inventor
Pietro Bianchini
Giuseppe Mascellani
Nicola Volpi
Original Assignee
Opocrin Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Opocrin Spa filed Critical Opocrin Spa
Publication of ITMI912310A0 publication Critical patent/ITMI912310A0/it
Priority to ITMI912310A priority Critical patent/IT1251183B/it
Priority to CA002116437A priority patent/CA2116437A1/en
Priority to AT92916443T priority patent/ATE160149T1/de
Priority to EP92916443A priority patent/EP0600928B1/en
Priority to PCT/EP1992/001790 priority patent/WO1993005074A1/en
Priority to ES92916443T priority patent/ES2110008T3/es
Priority to AU23962/92A priority patent/AU2396292A/en
Priority to KR1019940700570A priority patent/KR100233338B1/ko
Priority to US08/199,229 priority patent/US5547944A/en
Priority to DE69223153T priority patent/DE69223153T2/de
Priority to JP50486293A priority patent/JP3279316B2/ja
Priority to DK92916443T priority patent/DK0600928T3/da
Publication of ITMI912310A1 publication Critical patent/ITMI912310A1/it
Application granted granted Critical
Publication of IT1251183B publication Critical patent/IT1251183B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ITMI912310A 1991-08-28 1991-08-28 Dermatan solfato ad alto titolo, dotato di elevata attivita' trombolitica, e forme farmaceutiche che lo contengono. IT1251183B (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ITMI912310A IT1251183B (it) 1991-08-28 1991-08-28 Dermatan solfato ad alto titolo, dotato di elevata attivita' trombolitica, e forme farmaceutiche che lo contengono.
AU23962/92A AU2396292A (en) 1991-08-28 1992-08-06 Dermatan sulphate possessing a thrombolytic activity, and pharmaceutical forms containing it
US08/199,229 US5547944A (en) 1991-08-28 1992-08-06 Dermatan sulphate possessing a thrombolytic activity, and pharmaceutical forms containing it
EP92916443A EP0600928B1 (en) 1991-08-28 1992-08-06 Dermatan sulphate possessing a thrombolytic activity, and pharmaceutical forms containing it
PCT/EP1992/001790 WO1993005074A1 (en) 1991-08-28 1992-08-06 Dermatan sulphate possessing a thrombolytic activity, and pharmaceutical forms containing it
ES92916443T ES2110008T3 (es) 1991-08-28 1992-08-06 Dermatan sulfato que posee una actividad trombolitica y formulaciones farmaceuticas que lo contienen
CA002116437A CA2116437A1 (en) 1991-08-28 1992-08-06 Dermatan sulphate possessing a thrombolytic activity, and pharmaceutica l forms containing it
KR1019940700570A KR100233338B1 (ko) 1991-08-28 1992-08-06 혈전용해 활성을 갖는 황산 더마탄 및 이를 함유하는 약제학적 제형
AT92916443T ATE160149T1 (de) 1991-08-28 1992-08-06 Dermatansulfat mit trombolytischer wirkung und arzneiformen welche dieses enthalten
DE69223153T DE69223153T2 (de) 1991-08-28 1992-08-06 Dermatansulfat mit trombolytischer wirkung und arzneiformen welche dieses enthalten
JP50486293A JP3279316B2 (ja) 1991-08-28 1992-08-06 血栓溶解活性を有するデルマタンスルフェート及びこれを含有する製薬形態
DK92916443T DK0600928T3 (da) 1991-08-28 1992-08-06 Dermatansulfat, som har thrombolytisk aktivitet, og farmaceutiske former, som indeholder det

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI912310A IT1251183B (it) 1991-08-28 1991-08-28 Dermatan solfato ad alto titolo, dotato di elevata attivita' trombolitica, e forme farmaceutiche che lo contengono.

Publications (3)

Publication Number Publication Date
ITMI912310A0 ITMI912310A0 (it) 1991-08-28
ITMI912310A1 true ITMI912310A1 (it) 1993-02-28
IT1251183B IT1251183B (it) 1995-05-04

Family

ID=11360588

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI912310A IT1251183B (it) 1991-08-28 1991-08-28 Dermatan solfato ad alto titolo, dotato di elevata attivita' trombolitica, e forme farmaceutiche che lo contengono.

Country Status (12)

Country Link
US (1) US5547944A (it)
EP (1) EP0600928B1 (it)
JP (1) JP3279316B2 (it)
KR (1) KR100233338B1 (it)
AT (1) ATE160149T1 (it)
AU (1) AU2396292A (it)
CA (1) CA2116437A1 (it)
DE (1) DE69223153T2 (it)
DK (1) DK0600928T3 (it)
ES (1) ES2110008T3 (it)
IT (1) IT1251183B (it)
WO (1) WO1993005074A1 (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
CA2150552C (en) * 1993-09-30 1999-12-21 Akikazu Takada Antithrombotic
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US6106866A (en) * 1995-07-31 2000-08-22 Access Pharmaceuticals, Inc. In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
AU4938397A (en) * 1996-12-24 1998-07-17 Hyal Pharmaceutical Corporation Methods of elevating amounts of hyaluronan in the human body
GB9711443D0 (en) * 1997-06-03 1997-07-30 Leo Pharm Prod Ltd Chemical suppositions
FI974321A0 (fi) 1997-11-25 1997-11-25 Jenny Ja Antti Wihurin Rahasto Multipel heparinglykosaminoglykan och en proteoglykan innehaollande dessa
US6409987B1 (en) 1999-04-07 2002-06-25 Intimax Corporation Targeted agents useful for diagnostic and therapeutic applications
US6518244B2 (en) 2000-03-09 2003-02-11 Intimax Corporation Combinations of heparin cofactor II agonist and platelet IIb/IIIa antagonist, and uses thereof
US20050164983A1 (en) * 2003-12-19 2005-07-28 Aventis Pharma S.A. Carboxyl-reduced derivatives of dermatan sulfate, preparation thereof, use thereof as a medicinal product and the pharmaceutical compositions containing them
EP1745145A4 (en) * 2004-05-11 2008-03-26 Heptest Lab Inc COMPOSITIONS, KIT AND METHOD IN ONE STEP FOR MONITORING COMPOUNDS HAVING XA AND / OR ANTIFACTOR IIA ANTIFACTOR ACTIVITIES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3124384C2 (de) * 1981-06-22 1985-05-15 Herbert Prof. Dr. 1000 Berlin Voß Dermatanpolysulfat, Verfahren zu dessen Herstellung und dieses enthaltendes virushemmendes Mittel
IT1214609B (it) * 1985-05-17 1990-01-18 Opocrin Spa Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
IT1189085B (it) * 1986-03-25 1988-01-28 Mediolanum Farmaceutici Srl Processo per la preparazione di dermatan solfato ad alta purezza e composizioni farmaceutiche che lo contengono
WO1991015217A1 (en) * 1990-04-06 1991-10-17 Washington University Anticoagulant oligosaccharides

Also Published As

Publication number Publication date
AU2396292A (en) 1993-04-05
IT1251183B (it) 1995-05-04
ES2110008T3 (es) 1998-02-01
ATE160149T1 (de) 1997-11-15
JPH06510081A (ja) 1994-11-10
US5547944A (en) 1996-08-20
DK0600928T3 (da) 1998-07-27
WO1993005074A1 (en) 1993-03-18
KR100233338B1 (ko) 1999-12-01
EP0600928B1 (en) 1997-11-12
DE69223153D1 (de) 1997-12-18
ITMI912310A0 (it) 1991-08-28
EP0600928A1 (en) 1994-06-15
JP3279316B2 (ja) 2002-04-30
CA2116437A1 (en) 1993-03-18
DE69223153T2 (de) 1998-03-05

Similar Documents

Publication Publication Date Title
ITMI912310A1 (it) Dermatan solfato ad alto titolo, dotato di elevata attivita' trombolitica, e forme farmaceutiche che lo contengono.
BR9609063A (pt) Dinucleotídeos úteis para o tratamento de doenças pulmonares
DE69104723D1 (de) Hustenstillendes und schleimregulierendes mittel, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
CA2159591A1 (en) Aminosugar and Glycosaminoglycan Composition for the Treatment and Repair of Connective Tissue
MX163955B (es) Composicion farmaceutica de dihidrocodeina e ibuprofen
CA2289717A1 (en) Novel therapy for constipation
CA2213339A1 (en) Method of treating adenosine depletion
BR9807577A (pt) Método para prevenir e retardar o inìcio da doença de alzheimer e sua composição
CY2237B1 (en) Substituted pyrazolyl benzenesulfonamides for the
PT782449E (pt) Processo de fabrico de unidades de dosagem por granulacao humida
KR910000772A (ko) 1, 2―0―이소프로필리덴―α, D―글루코퓨라노오즈 유도체
DE3460577D1 (en) Sodium salt of ursodeoxycholic sulphate
EP0771191A4 (en) IMMUNOLOGICAL ACTIVITY OF RHAMNOLIPID
FR2737892B1 (fr) Nouveaux composes de benzenesulfonamide, procede de preparation et utilisation en therapeutique
TR26214A (tr) Baryum veya stronsiyum sulfid'in lavgalanma artiklarinin hazirlanmasi.
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
RU94013440A (ru) Производные 3-дезоксиолисахаридов, способы их получения и содержащие их фармацевтические композиции
NO302749B1 (no) Desferrioksamin-B-salter og anvendelse av disse for fremstilling av farmasöytiske sammensetninger
IT8722544A0 (it) Eparan solfato caratterizzato da elevata attivita' antitrombotica elevata biodisponibilita' assenza di attivita' anticoagulante; suo processo di estrazione da organi e da tessuti e relative composizioni farmaceutiche
NZ337798A (en) Pharmaceutical compositions containing lamivudine
KR880009654A (ko) 아세트알데히드의 독성을 감소시키는 조성물 및 방법
AU632578B2 (en) Dibenzo (1,5) dioxocin-5-one derivatives, their use in medicaments and processes for their preparation
DE69414716D1 (de) Pyridazinonderivate oder deren salze, verfahren zu ihrer herstellung und diese enthaltende antischockmittel
ES2128052T3 (es) Procedimiento para la preparacion de 4-amino-delta 4-3-cetoesteroides pasando por 4-nitro-delta 4-3-cetoesteroides.
BR9910185A (pt) Uso de um composto, e, processo para o tratamento de um paciente que sofre de, ou em risco de, uma doença micobacteriana

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960826